By: ICN Bureau
Last updated : November 04, 2026 9:00 pm
This exceptional growth propelled the EBITDA margin up by 794 basis points to 14.72%
Leading pharmaceutical excipient manufacturer Sigachi Industries Limited has announced its consolidated financial results for the second quarter of the fiscal year 2026-27 (Q2 FY27). The company delivered a robust operating recovery, highlighted by double-digit top-line growth and a significant surge in core operating profitability.
During the July–September 2026 quarter, Sigachi Industries recorded a consolidated revenue from operations of Rs. 130.46 crore, marking a steady growth of 18.08% year-on-year (YoY) compared to Rs. 110.48 crore in the corresponding period of the previous fiscal year. On a sequential quarter-on-quarter (QoQ) basis, revenue grew by 7.57% from Rs. 121.27 crore.
The standout highlight of the earnings update was the company's operating performance. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) skyrocketed by 156% YoY to reach Rs. 19.2 crore, up from Rs. 7.53 crore in Q2 FY26. This exceptional growth propelled the EBITDA margin up by 794 basis points to 14.72%. The profitability expansion was primarily driven by a stabilizing fixed-overhead environment and an enhanced product mix favoring high-margin specialized and co-processed grades.
Despite the powerful operational upswing, the company's bottom-line performance faced mild pressure from non-operating costs. Sigachi reported a Profit After Tax (PAT) of Rs. 8.78 crore, indicating a 15.24% YoY decline from Rs. 10.53 crore.